This exploration of eczema self-management investigated the potential effectiveness of 2 online behavioral interventions, 1 each for young patients and their parents and/or caregivers.
Online behavioral health interventions that complement usual care among children and young people with eczema and that also consider parental and carer contributions to self-care showed a sustained benefit at managing eczema severity, according to recent study findings in The BMJ.
“Despite the self-management of eczema presenting particular challenges, there have been few rigorously developed online interventions for eczema, and none have been evaluated in a trial large enough to detect differences in health outcomes,” the study authors wrote. “As parents and carers of children and young people with eczema are likely to have different support needs, we developed 2 separate interventions to be evaluated in 2 independent randomised controlled trials.”
Their analysis of data from the Eczema Care Online trials evaluated outcomes among parents and caregivers of children aged 0 to 12 years with eczema (trial 1) and young people aged 13 to 25 years (trial 2) receiving care at 98 general practices in England. In these parallel studies, participants were randomized 1:1 to usual care only or usual care plus an online intervention. Every 4 weeks for 24 weeks, eczema symptoms were evaluated via the Patient Oriented Eczema Measure (POEM), which grades eczema severity on a scale of 0 (clear or almost clear) to 28 (severe eczema). Secondary outcomes included eczema control and itch intensity. In trial 1, 169 parents/carers were randomized to usual care and 171, the intervention plus usual care. For trial 2, there were 169 and 168 young people, respectively. Follow-up finished on December 31, 2021, after recruitment that took place from December 2, 2019, to December 8, 2020.
At baseline, the mean (SD) overall POEM score was 12.8 (5.3) in trial 1 and 15.2 (5.4) in trial 2. Follow-up rates were high at the 24-week mark, at 91.5% of the parents and carers and 90.2% of the young people.
Compared with usual care, eczema improved among those randomized to the intervention plus usual care by a mean –1.5 (95% CI, –2.5 to –0.6; P = .002) among the parents and carers, and this rose to –1.9 (95% CI, –3.0 to –0.8; P < .001) among the young people. In addition, follow-up that extended to 52 weeks shows POEM scores and eczema improvement were sustained. Follow-up rates also remained high at 52 weeks, at 89.1% in trial 1 and 84.0% in trial 2.
A statistically significant difference was seen overall that favored both intervention groups, with adjusted mean differences of −0.7 (95% CI,−1.0 to −0.4) for parents or carers and −0.9 (95% CI, −1.3 to −0.6) for young people at 24 weeks.
In trial 1, 92% of the parents/carers were women, 83% of participants were White, and 62% had moderate eczema. For trial 2, these totals were 77%, 86%, and 55%, respectively. During both trials at baseline, participants were queried on how effective they thought online interventions were or if they had ever used website or apps for eczema management.
The study investigators noted that their number needed to treat was 6 (parents and carers, 95% CI, 3-13; young people, 95% CI, 4-18) in both trials, if they hoped to achieve a 2.5 improvement in POEM score at 24 weeks. This finding, they highlighted, “compares favorably with many drug treatments and is particularly important in the absence of identifiable harms and in the context of a low cost and highly scalable intervention.”
Even with their positive findings, the study researchers wrote that more research is needed on effective eczema management in a more specialized setting, because most people with eczema are managed in the primary care setting in the United Kingdom.
Still, they believe their online intervention can be adapted to other health care settings.
“A small amount of benefit at low cost with no identifiable harms for a condition that affects a large number of people can lead to substantial health benefit for the public in absolute terms,” the authors concluded. “The findings reinforce the key role of health professionals in signposting patients and carers toward self-management support for long term conditions.”
Reference
Santer M, Muller I, Becque T, at al. Eczema Care Online behavioural interventions to support self-care for children and young people: two independent, pragmatic, randomised controlled trials. BMJ. Published online December 7, 2022. doi:10.1136/bmj-2022-072007
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
Examining Telehealth Uptake to Increase Equitable Care Access
January 26th 2023To mark the publication of The American Journal of Managed Care®’s 12th annual health IT issue, on this episode of Managed Care Cast, we speak with Christopher M. Whaley, PhD, health care economist at the RAND Corporation, who focuses on health economics issues, including the influence of the COVID-19 pandemic on health care delivery.
Listen
Bioinformatics, Machine Learning Reveal New Insights Into MG-Associated DCM
April 11th 2024Researchers explain that these insights have important implications, if validated in further research, as challenges with early detection of dilated cardiomyopathy complicate myasthenia gravis (MG)-prognosis.
Read More
What We’re Reading: Telehealth Debate; STD Rise Among Older Adults; PFAS Limits in Water
April 10th 2024Lawmakers are under pressure to decide the fate of COVID-era telehealth payment changes; the CDC reports an alarming increase in sexually transmitted disease (STD) cases among Americans 55 years and older; new regulations aim to reduce harmful exposure to per- and polyfluoroalkyl substances (PFAS), also known as “forever chemicals.”
Read More